Insider · CIK 0001845487
June Bray
Files at QNCX (Quince Therapeutics, Inc.), BTAIQ (BioXcel Therapeutics, Inc.). First filing -, latest -.
June Bray files SEC Form 4 as director at QNCX (Quince Therapeutics, Inc.), and also at BTAIQ (BioXcel Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; June Bray has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | QNCX Quince Therapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +18,724 | $0.00 | $0 | 18,724 | Jan 21, 2026 |
| Jan 9, 2026 | BTAIQ BioXcel Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,000 | $0.00 | $0 | 17,000 | Jan 12, 2026 |
| Jun 4, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +27,000 | $0.00 | $0 | 27,000 | Jun 6, 2025 |
| Jan 2, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +30,282 | $0.00 | $0 | 30,282 | Jan 8, 2025 |
Questions about June Bray
Answered from the filings on this page, as of the latest one.
Is June Bray buying or selling?
June Bray has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did June Bray's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and June Bray has 0.
Where does June Bray file Form 4?
June Bray has filed Form 4 at QNCX (Quince Therapeutics, Inc.); BTAIQ (BioXcel Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.